Document is current
Any future updates will be listed below
-
Authors
Woo, Sungmin https://orcid.org/0000-0001-8459-8369
Freedman, Daniel
Becker, Anton S.
Leithner, Doris
Charbel, Charlotte
Mayerhoefer, Marius E.
Friedman, Kent P.
Tong, Angela
Wise, David R.
Taneja, Samir S.
Zelefsky, Michael J.
Vargas, Hebert Alberto
- License Information
-
More Information
Article History
Received: 2 March 2025
Revised: 30 March 2025
Accepted: 8 April 2025
First Online: 19 April 2025
Declarations
:
: M.E.M. received honoraria for lectures from Siemens, GE, and BM but unrelated to the current work. K.P.F. is a co-investigator on “Optimizing timing of rhPSMA-7.3 (18F), for assessing site(s) of recurrent disease following radical prostatectomy” (PI Herbert Lepor) but does not receive any salary support and is unrelated to the current work. D.R.W. has received consulting fees from Leap Therapeutics, Foundation Medicine, Pfizer, Janssen, Sanofi, Lilly, Labcorp, Myovant, Bayer, AstraZeneca, Accutar and has received travel funding from Pfizer and Bayer but unrelated to the current work. The other authors have nothing to disclose.
